A matching-adjusted indirect comparison of acalabrutinib versus zanubrutinib in relapsed or refractory chronic lymphocytic leukemia.
Adam S KittaiAlan SkarbnikMiguel MirandaAlan S M YongJack RoosRobert HettleSarah Palazuelos-MunozVikram ShettyPaolo GhiaPublished in: American journal of hematology (2023)